Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Germ Cell Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01483820
What this trial is testing

Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma

Who this might be right for
NeuroblastomaMedulloblastoma
Giselle Sholler 8
Testing effectiveness (Phase 2)Looking for participantsNCT06013618
What this trial is testing

Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma

Who this might be right for
Neuroblastoma
Sun Yat-Sen University Cancer Center 120
Early research (Phase 1)Active Not RecruitingNCT06577987
What this trial is testing

Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorRefractory Solid Tumor+7 more
Circle Pharma 220
Early research (Phase 1)Study completedNCT03206021
What this trial is testing

COZMOS:Phase I/Ib Trial of Combined 5'Azacitidine and Carboplatin for Recurrent/Refractory Pediatric Brain/Solid Tumors

Who this might be right for
Recurrent Childhood CNS TumorEpendymoma, Recurrent ChildhoodChildhood Solid Tumor
The Hospital for Sick Children 31
Not applicableStudy completedNCT00049465
What this trial is testing

Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT03603379
What this trial is testing

Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas

Who this might be right for
Glioblastoma
University Hospital, Basel, Switzerland 9
Testing effectiveness (Phase 2)Study completedNCT04305041
What this trial is testing

Substudy 02A: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents in Participants With Programmed Cell-death 1 (PD-1) Refractory Melanoma (MK-3475-02A/KEYMAKER-U02)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 100
Early research (Phase 1)Ended earlyNCT00054405
What this trial is testing

Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma

Who this might be right for
Recurrent Neuroblastoma
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Ended earlyNCT00729807
What this trial is testing

0794GCC: Pentamidine in Treating Patients With Relapsed or Refractory Melanoma

Who this might be right for
Melanoma (Skin)
University of Maryland, Baltimore 6
Testing effectiveness (Phase 2)Study completedNCT01239316
What this trial is testing

Vismodegib in Treating Younger Patients With Recurrent or Refractory Medulloblastoma

Who this might be right for
Recurrent Childhood Medulloblastoma
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT00436852
What this trial is testing

ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
Disseminated NeuroblastomaRecurrent Neuroblastoma
Children's Oncology Group 92
Testing effectiveness (Phase 2)Study completedNCT00183820
What this trial is testing

Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma

Who this might be right for
Testicular CancerGerm Cell Neoplasm
University of Southern California 30
Testing effectiveness (Phase 2)Study completedNCT00509288
What this trial is testing

Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered Lymphocytes

Who this might be right for
MelanomaSkin Cancer
National Cancer Institute (NCI) 24
Early research (Phase 1)Looking for participantsNCT07488923
What this trial is testing

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

Who this might be right for
Small Cell Lung Cancer (SCLC )Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)Gastroenteropancreatic NEC (GEP NEC)+1 more
Moonlight Bio, Inc 110
Testing effectiveness (Phase 2)Study completedNCT02343224
What this trial is testing

Pegylated Interferon ALFA-2b in Children With Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas

Who this might be right for
Juvenile Pilocytic AstrocytomasOptic Pathway Gliomas
Emory University 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Not applicableStudy completedNCT01109238
What this trial is testing

A Trial Using Molecular-Guided Therapy in Patients With Refractory or Recurrent Neuroblastoma

Who this might be right for
Refractory NeuroblastomaRelapsed Neuroblastoma
Giselle Sholler 5
Testing effectiveness (Phase 2)WithdrawnNCT00874315
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.

Who this might be right for
Neuroblastoma
Nationwide Children's Hospital
Early research (Phase 1)UnknownNCT00002647
What this trial is testing

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsMetastatic Cancer
Medical College of Wisconsin 24
Not applicableStudy completedNCT00293384
What this trial is testing

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Barbara Ann Karmanos Cancer Institute 40
Next Page